TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma
Émeline Tabouret(Assistance Publique Hôpitaux de Marseille), Zhengping Zhuang(National Cancer Institute)
Cited by 15
Related Papers
Somatic<i>HIF2A</i>Gain-of-Function Mutations in Paraganglioma with Polycythemia
|New England Journal of Medicine|2012|391
Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha
|Oncotarget|2017|81
Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones
|Proceedings of the National Academy of Sciences|2012|78
Celastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones
|Proceedings of the National Academy of Sciences|2013|45